Differences in presentation of younger and older systemic sclerosis (SSc) patients in clinical trials. After adjustment for population norms and potential confounders, including medications, only differences in alkaline phosphatise and CK (muscle enzymes) remain between younger and older patients with SSc. Overall, older patients with SSc in clinical trials seem to be more similar to younger patients than was previously thought. Weng HH. (PubMed) Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 62):S10-4. (Also see: Clinical Trials)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
Differences in presentation of younger and older systemic sclerosis (SSc) patients in clinical trials
No replies to this topic